to Advanced Connection Corporation Public Company Limited (“the Company”) has received financial relief from the Company and subsidiaries for 3 months approval for the year ended 31 March 2020. It

Connection Corporation Public Company Limited, the “Company” has submitted the financial statements of the Company and its subsidiaries for the year 2020 ended 31 December 2020, it appears that the operating

Advanced Connection Corporation Public Company Limited (“the Company”) has received financial relief from the company and subsidiaries for 3 months approval for the quarter 1/2021 ended 31 March 2021. It

other relevant agreements and documents, to proceed with necessary and proper actions required in connection to the disposition of the above Planet’s ordinary shares in order to the complete such

Type 2 Transaction (List 1). DOD Biotech Public Company Limited (the “Company”) hereby notifies the significant resolutions passed by the Board of Directors’ Meeting No. 8/2018, held on December 19, 2018

Acquisition of Assets of DOD Biotech Public Company Limited regarding the Acquisition of Land and Establishment of Subsidiary, which is Class 2 Transaction (Schedule 1) DOD Biotech Public Company Limited ( the

any facts that are material. 3. Opinions of the independent expert on the entering into the transaction The Company has appointed Capital Advantage Company Limited as the independent financial advisor

. 2 The said voluntary tender offer for all securities in TBSP constitutes an asset acquisition transaction pursuant to the Notification of the Capital Market Supervisory Board No. TorChor. 20/2551 Re

other actions pursuant to the Takeover Notification. 2 The said voluntary tender offer for all securities in TBSP constitutes an asset acquisition transaction pursuant to the Notification of the Capital

asset acquisition transaction pursuant to the Notification of the Capital Market Supervisory Board No. TorChor. 20/2551 Re: Rules on Entering into Material Transactions Deemed as Acquisition or Disposal